| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996533 | Practical Radiation Oncology | 2016 | 10 Pages |
Abstract
SBRT is effective for selected patients with hepatic oligometastases with limited toxicities. A phase 3 trial comparing SBRT with "gold-standard" surgical resection is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Benjamin D. DO, Edward M. MD, MPH, MS, Sandra K. MS, Mary A. MD, MPH, Higinia R. MD, PhD,